These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20022823)

  • 41. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The perspective of liver transplantation for cholangiocarcinoma.
    Jonas S; Neuhaus P
    Liver Transpl; 2007 Oct; 13(10):1358-61. PubMed ID: 17902140
    [No Abstract]   [Full Text] [Related]  

  • 43. Increasing incidence of cholangiocarcinoma in Crete 1992-2000.
    Mouzas IA; Dimoulios P; Vlachonikolis IG; Skordilis P; Zoras O; Kouroumalis E
    Anticancer Res; 2002; 22(6B):3637-41. PubMed ID: 12552969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of radiation therapy in intrahepatic cholangiocarcinoma.
    Metz JM
    Cancer J; 2006; 12(2):102-4. PubMed ID: 16630398
    [No Abstract]   [Full Text] [Related]  

  • 45. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
    Björnsson E; Angulo P
    Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical procedure and prognosis of hilar cholangiocarcinoma.
    Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Improved treatment results in hilar cholangiocarcinoma after transition to more extensive procedure: 20 years experience AMC].
    van Gulik TM; Kloek JJ; Ruys AT; Busch OR; van Tienhoven G; Lameris JS; Rauws EA; Gouma DJ
    Ned Tijdschr Geneeskd; 2010; 154():A1815. PubMed ID: 20858305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distal cholangiocarcinoma.
    Liu K
    J Surg Oncol; 2007 Mar; 95(3):192-3. PubMed ID: 17323332
    [No Abstract]   [Full Text] [Related]  

  • 53. Biliary ascariasis and extrahepatic cholangiocarcinoma.
    Toufeeq Khan TF; Muniandy S
    Singapore Med J; 1995 Oct; 36(5):570. PubMed ID: 8882553
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bile duct cysts in adults].
    Kupferschmidt H; Schwery S; Schmid PA; Bühler H
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1117-23. PubMed ID: 9312834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases.
    Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
    Shitara K; Ikami I; Munakata M; Muto O; Sakata Y
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transplantation for cholangiocarcinoma.
    Sudan DL
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S83-4. PubMed ID: 17051566
    [No Abstract]   [Full Text] [Related]  

  • 59. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results.
    Seehofer D; Thelen A; Neumann UP; Veltzke-Schlieker W; Denecke T; Kamphues C; Pratschke J; Jonas S; Neuhaus P
    Liver Transpl; 2009 Nov; 15(11):1499-507. PubMed ID: 19877250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.